Description
Temozolomideisasecondgenerationimidazotetrazineanticancerchemotherapeuticthatisclinicallyapprovedtotreatgliobastomamultiforme,anaplasticastrocytoma,andoligodendrocytoma.Temozolomideactsasanalkylatingagent,attachingalkylgroupstoguaninebasesinDNAandinterferingwithDNAreplication.Thiscompoundis100%orallybioavailableandentersthecerebrospinalfluideasilyandquickly.
References
NagasawaDT,ChowF,YewA,etal.Temozolomideandotherpotentialagentsforthetreatmentofglioblastomamultiforme.NeurosurgClinNAm.2012Apr;23(2):307-22,ix.PMID:22440874.
WesolowskiJR,RajdevP,MukherjiSK.Temozolomide(Temodar).AJNRAmJNeurorADIol.2010Sep;31(8):1383-4.PMID:2053882.
FriedmanHS,KerbyT,CalvertH.Temozolomideandtreatmentofmalignantglioma.ClinCancerRes.2000Jul;6(7):2585-97.PMID:10914698.
HoringE,HarterPN,SeznecJ,etal.The“goorgrow”potentialofgliomasislinkedtothenecropeptideprocessingenzymecarboxypeptidaseEandmediatedbymetabolicstress.ActaNeuropathol.2012Jul;124(1):83-97.PMID:22249620.
MomiyamaM,SuetsuguA,ChishimaT,etal.Subcellularreal-timeimagingoftheefficacyoftemozolomideoncancercellsinthebrainoflivemice.AnticancerRes.2013Jan;33(1):103-106.PMID:23267133.